Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing

Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing

FromThe BMJ Podcast


Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing

FromThe BMJ Podcast

ratings:
Length:
43 minutes
Released:
Apr 9, 2020
Format:
Podcast episode

Description

For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral

10.00 - The importance and difficulty of making guidelines now

15.00 - We hear from guideline maker Per Vandvik, about making guidance.

21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv.

31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain.

Reading list:
www.bmj.com/coronavirus

Rapidly managing pneumonia in older people during a pandemic
https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/

https://www.medrxiv.org/

Covid-19: testing times
https://www.bmj.com/content/369/bmj.m1403
Released:
Apr 9, 2020
Format:
Podcast episode

Titles in the series (100)

The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our mission is to lead the debate on health and to engage, inform, and stimulate doctors, researchers, and other health professionals in ways that will improve outcomes for patients. We aim to help doctors to make better decisions.